Common Cancer Patterns and Metastatic Sites

Common Cancer Patterns and Metastatic Sites

Pattern Recognition Without Overdiagnosis

The OCN benefits from knowing typical patterns of spread, but pattern recognition is not diagnosis. It helps the nurse ask better questions, teach reportable symptoms, and escalate concerning change. Metastasis follows tumor biology, blood and lymphatic drainage, molecular subtype, treatment history, and host factors. The "seed and soil" concept explains why specific tumors favor specific organs: tumor cells (seeds) thrive only in compatible microenvironments (soil).

Spread occurs by three main routes — lymphatic (often the first stop in regional nodes), hematogenous (bloodborne, favoring lung, liver, bone, and brain), and direct seeding across body cavities such as the peritoneum. Knowing the dominant route for a given primary tells the nurse which symptoms to prioritize.

High-Yield Solid-Tumor Spread Patterns

Breast, Lung, and Colorectal

Breast cancer behavior depends on receptor subtype. Estrogen-receptor-positive disease often follows a long course with bone-predominant spread; triple-negative and HER2-positive disease more often involve viscera and brain. The nurse assesses new focal bone pain, headache, vision change, seizure, cough, dyspnea, and chest-wall change.

Lung cancer divides into non-small cell and small cell. Small cell is strongly associated with paraneoplastic syndromes (SIADH, Lambert-Eaton). Lung cancer can cause airway obstruction, malignant pleural effusion, hemoptysis, superior vena cava (SVC) syndrome, and brain, bone, and adrenal metastases. Escalate new facial or neck swelling, distended neck veins, dyspnea, confusion, or severe headache.

Colorectal cancer spreads to liver via the portal vein and to lung and peritoneum. The nurse monitors bowel pattern, bleeding, obstruction symptoms, oxaliplatin-induced cold-triggered neuropathy, ostomy concerns, and hand-foot syndrome from capecitabine or fluorouracil.

Genitourinary, Gynecologic, and Skin Cancers

Prostate cancer favors the axial skeleton (spine, pelvis), creating high risk for spinal cord compression. Red flags: new back pain, leg weakness, saddle anesthesia, urinary retention, or severe constipation. Kidney cancer is vascular, may bleed, and can cause paraneoplastic hypercalcemia; it spreads to lung, bone, brain, and liver. Bladder cancer presents with painless hematuria and may involve pelvis, lung, liver, bone, or nodes.

Ovarian cancer often presents late with vague abdominal symptoms, peritoneal seeding, ascites, and early satiety. Endometrial cancer typically presents with postmenopausal bleeding. Cervical cancer is HPV-driven and may cause abnormal bleeding and pelvic or urinary symptoms. The nurse normalizes reporting pelvic bleeding while escalating heavy bleeding, severe pain, fever, obstruction, or signs of ureteral obstruction.

Melanoma can metastasize anywhere, including brain and gastrointestinal tract. Assess new neurologic symptoms, GI bleeding, new subcutaneous nodules, and immune-related adverse events when checkpoint inhibitors are used.

Hematologic Malignancies

Leukemias, lymphomas, and myeloma behave very differently from solid tumors.

Leukostasis (very high blast count) and hyperviscosity are emergencies the OCN must recognize. Myeloma's CRAB criteria are a high-yield memory aid.

Metastatic Site Symptom Clusters

• Bone: focal pain, pathologic fracture, hypercalcemia, cord compression.
• Liver: right-upper-quadrant pain, jaundice, pruritus, ascites, abnormal liver tests.
• Lung/pleura: dyspnea, cough, chest pain, hypoxia, effusion.
• Brain: headache, seizure, focal weakness, vision change, confusion, personality change.
• Peritoneum: ascites, bowel obstruction, nausea, distention.

The nurse clusters these findings against the known primary and treatment history to decide whether the situation needs same-day oncology evaluation or emergency care, then escalates with precise, trend-based data rather than a vague "patient feels worse."

Site-Specific Surveillance and Survivorship Awareness

Pattern knowledge also shapes survivorship teaching. After curative treatment, surveillance is tailored to where a given cancer tends to recur: colorectal survivors follow scheduled CEA, colonoscopy, and CT; breast survivors continue mammography and clinical exams; lung survivors undergo periodic CT. The OCN reinforces adherence to the survivorship care plan, teaches reportable symptoms tied to the likely recurrence sites, and watches for late and long-term effects such as anthracycline cardiotoxicity, platinum-related neuropathy and ototoxicity, secondary malignancies, and lymphedema after axillary surgery or radiation.

Framing surveillance around the tumor's known behavior helps patients understand why specific tests recur on a schedule and which new symptoms truly warrant a call rather than waiting for the next visit.